Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

CVS Health (CVS) Tops Q1 Earnings and Revenue Estimates

Ever bought medicines or cosmetics over the counter? Yes, then you may have walked into one of the 7,700 retail CVS/pharmacy stores of the largest pharmacy healthcare services provider in the U.S. – CVS Health Corporation CVS. This Rhode Island-based company’s more than 900 walk-in medical clinics–CVS/MinuteClinic currently possess a customer satisfaction rate of 95%.

Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its strong first quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings:The Zacks Consensus Estimate remained steady at $1.16 per share over the last 60 days. CVS Health’s adjusted earnings per share of $1.18 beat this estimate by 1.7%.

Revenues:CVS Health posted revenues of $43.215 billion, comfortably beating the Zacks Consensus Estimate for revenues of $42.976 billion.

Key Stats: CVS Health’s Pharmacy Services segment revenues increased 20.5% to $28.8 billion, while revenues from Retail/LTC segment improved 18.6% year over year to $20.1 billion. During the first quarter, CVS Health opened 24 new retail drugstores, and closed 5 retail stores. Further, the company relocated 14 retail drugstores.

Major Factors: CVS Health started off 2016 on a promising note, with better-than-expected first quarter results. However management reiterated the company’s 2016 adjusted EPS guidance, despite both the segments reported solid year over year growth. For the first quarter, the generic dispensing rate increased 170 basis points to 85.2% in the Pharmacy Services Segment and 125 basis points to 85.7% in the Retail/LTC Segment.

Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this CVS Health earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CVS HEALTH CORP (CVS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research